Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
This study will determine the effectiveness of a vaccine communication mobile health app on parental decisions to vaccinate their children against coronavirus disease 2019 (COVID-19). The hypothesis is that unvaccinated children of caregivers assigned to the Vaccine Uptake app will be more likely to achieve COVID-19 vaccine series completion than those children whose caregivers are assigned to the General Health app.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Mar 11, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- IDeA States Pediatric Clinical Trials Network
- Interventions being studied
- Behavioral: COVID-19 Vaccine Uptake App; Other: General Health App
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Parent/Caregiver
- Age of majority, as defined by the state of residency
- Access to a mobile device that can store and run the study app for 24 weeks. Devices that can run the app include mobile phones and tablets running Android or iOS operating systems
- Able to speak and read in English or Spanish
- Be a parent/caregiver with primary medical decision-making and legal authority to consent to vaccination decisions for at least one child who meets the child inclusion criteria Child Inclusion Criteria:
- Age 6 months to less than age of majority, as defined by the child's state of residence
- Has not received any doses of COVID-19 vaccine based on parent/caregiver report
- Eligible to receive COVID-19 vaccine
- Patient at a participating clinic Parent/Caregiver
- Has only a child or children with known contraindication to all COVID-19 vaccines
- Has only a child or children whose other parent/caregiver is already a current or past participant in the study
- Has a child or children enrolled in any other COVID-19 vaccine study of any kind
- Past or present participation in a COVID-19 vaccine or behavioral trial
- Has a cognitive impairment that limits their ability to engage with the app content and/or make medical decisions regarding vaccination, based on the site investigator's assessment and local human subjects research policies Child
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Arkansas Children's Research InstituteLittle Rock, Arkansas
- Nemours Children's HealthWilmington, Delaware
- Kapiolani Medical Center for Women and ChildrenHonolulu, Hawaii
- University of Kansas Medical CenterKansas City, Kansas
- Norton Children's Research InstituteLouisville, Kentucky
- Our Lady of the Lake Regional Medical CenterBaton Rouge, Louisiana
- University of Mississippi Medical CenterJackson, Mississippi
- University of Nebraska Medical CenterOmaha, Nebraska
- Dartmouth Hitchcock ClinicLebanon, New Hampshire
- University of New Mexico Health Sciences CenterAlbuquerque, New Mexico
- University of Oklahoma Health Sciences CenterOklahoma City, Oklahoma
- Rhode Island HospitalProvidence, Rhode Island
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 11, 2025. Always confirm current availability with the study team.